WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Sex Steroids, Sleep, and Metabolic Dysfunction in Women
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 61
- Registration Number
- NCT00805207
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00802815
- Locations
- πΊπΈ
Washington University Department of Neurology, Saint Louis, Missouri, United States
Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2017-02-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT00802880
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2014-12-05
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT00802659
- Locations
- πΊπΈ
Washington University, St. Louis, Missouri, United States
The Effect of an Azygos Vein Coil on Defibrillation Threshold
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2018-09-28
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT00798174
- Locations
- πΊπΈ
Washington University, Saint Louis, Missouri, United States
Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2018-05-03
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT00798915
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-25
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT00797056
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Temsirolimus and Radiation for Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2013-07-11
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT00796796
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 42
- Registration Number
- NCT00795288
- Locations
- πΊπΈ
Washington Univeristy, ST Louis, Missouri, United States
Omega-3 Fatty Acids and Muscle Protein Synthesis
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 43
- Registration Number
- NCT00794079
- Locations
- πΊπΈ
Washington University in Saint Louis, Saint Louis, Missouri, United States
Β© Copyright 2024. All Rights Reserved by MedPath